Lipopolysaccharide induced protection against sulfur mustard cytotoxicity in RAW264.7 cells through generation of TNF-α

Journal of Toxicological Sciences

Volumn 35, Issue 3, 2010, Pages 345-355

  Allon, Nahum ^a   Chapman, Shira ^a   Shalem, Yoav ^a   Brandeis, Rachel ^a   Weissman, Ben Avi ^a   Amir, Adina ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

Cytotoxicity; LPS; NO; RAW 264.7; Sulfur mustard; TNF

Indexed keywords

DEXAMETHASONE; DICLOFENAC; DOXYCYCLINE; LIPOPOLYSACCHARIDE; MUSTARD GAS; NITRIC OXIDE; PROSTAGLANDIN E2; S NITROSOGLUTATHIONE; TUMOR NECROSIS FACTOR ALPHA; ALKYLATING AGENT;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CHEMICAL ANALYSIS; CYTOKINE RELEASE; CYTOTOXICITY; DRUG EXPOSURE; INFLAMMATION; MOUSE; NONHUMAN; ANIMAL; CELL LINE; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; MACROPHAGE; METABOLISM; PHYSIOLOGY; TOXICITY;

MURINAE;

ALKYLATING AGENTS; ANIMALS; CELL DEATH; CELL LINE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MUSTARD GAS; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77953298508     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.35.345     Document Type: Article

References (50)

1. Allon, N., Gilat, E., Amir, A., Fishbein, E., Liani, H., Halperin, B., Sahar, R., Manisterski, E. and Kadar, T. (1993): Sulfur mustard inhalation induced respiratory lesions in guinea pigs: physiological, biochemical and histological study. In Medical Defence Bioscience Review, 133-139.
2. Amir, A., Chapman, S., Gozes, Y., Sahar, R. and Allon N. (1998): Protection by extracellular glutathione against sulfur mustard induced toxicity in vitro. Hum. Exp. Toxicol., 17, 652-660.
3. Amir, A., Turetz, J., Chapman, S., Fishbeine, E., Meshulam, J., Sahar, R., Liani, H., Gilat, E., Frishman, G. and Kadar, T. (2000): Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits. J. Appl. Toxicol., Suppl. 1, 109-114.
4. Amir, A., Chapman, S., Kadar, T., Gozes, Y. and Allon, N. (2000): Sulfur mustard toxicity in macrophages: effects of dexamethasone. J. Appl. Toxicol., Suppl. 1, s51-s58.
5. Arroyo, C.M., von Tersch, R.L. and Broomfield, C.A. (1995): Activation of alpha-human tumor necrosis factor (TNF-alpha) by human monocytes (THP-1) exposed to 2-chloroethyl ethyl sulfide (H-MG). Hum. Exp. Toxicol., 14, 547-553.
6. Arroyo, C.M. and Carmichael, A.J. (1997): Role of cytokine and nitric oxide in the inflammatory response produced by sulfur mustard (HD). J. Chem. Soc. Perkin. Trans., 2, 2495-2499.
7. Arroyo, C.M., Schafer, R.J., Kurt, E.M., Broomfield, C.A. and Carmichael, A.J. (2000): Response of normal human keratinocytes to sulfur mustard : cytokine release. J. Appl. Toxicol., 1, S63-S72.
8. Bannerman, D.D. and Goldblum, S.E. (2003): Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis. Am. J. physiol. Lung Cell Mol. Physiol., 284, L899-L914.
9. Calvet, J.H., Jarreau, P.H., Levame, M., D'Ortho, M.P., Lorino, H., Harf, A. and Macquin-Mavier, I. (1994) : Acute and chronic respiratory effects of sulfur mustard intoxication in guinea pig. J. Appl. Physiol., 76, 681-688.
10. Calvet, J.H., Planus, E., Rouet, P., Pezet, S., Levame, M., Lafuma, C., Harf, A. and D'Ortho, M.P. (1999): Matrix metalloproteinase gelatinases in sulfur mustard-induced acute airway injury in guinea pigs. Am. J. Physiol., 276, L754-L762.
11. Casillas, R.P., Kiser, R.C., Truxall, J.A., Singer, A.W., Shumaker, S.M., Niemuh, N.A., Ricketts, K.M., Mitcheltree, L.W., Castrejon, L.R. and Blank, J.A. (2000): Therapeutic approuches to dermatoxicity by sulfur mustard. I. Modulation of sulfur mustard-induced cutaneous unjury in the mouse ear vesicant model. J. App. Toxicol., 1, S145-S151.
12. Chapman, S., Kadar, T., Allon, N., Gozes, Y. and Amir, A. (2000): Differential response of corneal-epithelial and macrophage cell lines to sulfur mustard: Effects of anti-inflammatory drug treatments Proceedings of the Medical Defense Bioscience Review, Baltimore MD, pp.1014-1023.
13. Chen, C.C., Chiu, K.T., Sun, Y.T. and Chen, W.C. (1999): Role of the cyclic AMP-protein kinase A pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages. Involvement of cyclooxygenase-2. J. Biol. Chem., 274, 31559-31564.
14. Dachir, S., Fishbine, E., Meshulam, Y., Sahar, R., Amir, A. and Kadar, T. (2002): Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model. Hum. Exp. Toxicol., 21, 197-203.
15. Dannenberg, A.M., Pula, P.J.Jr., Liu, L.H., Harada, S., Tanaka, F., Vogt, R.F., Kajiki, A.Jr. and Higuchi, K. (1985): Inflammatory mediators and modulators released in organ culture from rabbit skin lesions produced in vivo by sulfur mustard. I. Quntitative histopathology; PMN, basophile, and mononuclear cell survival; and unbound (serum) protein content. Am. J. Pathol., 121, 15-27.
16. Dannenberg, A.M.Jr., Schofield, B.H., Rao, J.B., Dinh, T.T., Lee, K., Boulay, M., Abe, Y., Tsuruta, J. and Steinbeck., M. J. (1994): Histochemical demonstration of hydrogen peroxide production by leukocytes in fixed-frozen tissue sections of inflammatory lesions. J. Leukoc. Biol., 56, 436-443.
17. Dillman, J.F.III., McGary, K.L. and Schlager, J.J. (2004): An inhibitor of p38 MAP kinase downregulates cytokine release induced by sulfur mustard exposure in human epidermal keratinocytes. Toxicol. in vitro, 18, 593-599.
18. Echtenacher, B. and Mannel, D.N. (2002): Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis. J. Endotoxin. Res., 8, 365-369.
19. Gao, X., Ray, R., Xiao, Y., Barker, P.E. and Ray, P. (2007): Inhibition of sulfur mustard-induced cytotoxicity and inflammation by the macrolide antibiotic roxithromycin in human respiratory epithelial cells. BMC Cell Biol., 24, 8-17. (Pubitemid 46939417)
20. Gaur, U. and Aggarwal, B.B. (2003): Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem. Pharmacol., 66, 1403-1408.
21. Geckel, P.T. (1951): Colorimetric method for estimation of mustard and sesqui in mixtures of mustard and sesqui in. TCR 80 Chemical Corps, Chemical and Radiological Laboratoeies, Army Chemical center MD. February 1951.
22. Hattori, Y., Kasai, K. and Gross, S.S. (2004): No suppresses while peroxynitrite sustains NF-kappaB: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO. Cardiovasc Res., 63, 31-40. (Pubitemid 38759807)
23. Hodyl, N.A., Krivanek, K.M., Lawrence, E., Clifton, V.L. and Hodgson, D.M. (2007) : Prenatal exposure to a pro-inflammatory stimulus causes delays in the development of the innate immune response to LPS in the offspring. J. Neuroimmunol., 190, 61-71. (Pubitemid 47625608)
24. Ishida, H., Ray, R. and Ray, P. (2008): Sulfur mustard downregulates iNOS expression to inhibit wound healing in a human keratinocyte model. J. Dermatol. Sci., 49, 207-216.
25. Kadar, T., Amir, A., Fishbein, E., Chapman, S., Liani, H., Sahar, R., Rabinowitz, I., Simon, G.A., Frishman, G., Sheivitz, R. and Turetz, J. (1996): The potential therapy of steroids against ocular lesions induced by sulfur mustard vapor in rabbits. In Medical Defense Bioscience Review, 845-852.
26. Kim, Y. S., Kim, S.S., Cho, J.J., Choi, D.H., Hwang, O., Shon, D.H., Chum, H.S., Beal, M.F. and Joh, T.H. (2005): Matrix metalloprotease-3: A novel signaling proteinase from apoptotic neuronal cells that activates microglia. J. Neuroscience, 25, 3701-3711. (Pubitemid 40503697)
27. Lozano-Sánchez, F.S., Gonzalez-Sarmiento, R. (2007): Systemic inflammatory response, bacterial translocation and nitric oxide donors. Inflamm. Allergy Drug Targetes, 6, 139-141.
28. Mallis, R.J., Buss, J.E. and Thomas, J.A. (2001): Oxidative modification of H-ras: S-thiolation and S-nitrosylation of reactive cysteines. Biochem. J., 355, 145-153.
29. Manna, S.K., Zhang, H.J., Yan, T., Oberley, L.W. and Aggarwal, B.B. (1998): Overexpression of manganese super oxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa-B and activated protein-1. J. Biol. Chem., 273, 13245-13254.
30. Mariotto, S., Suzuki, Y., Persichini, T., Colasanti, M., Suzuki, H. and Cantoni, O. (2007): Cross-talk between NO and arachdonic acid in inflammation. Curr. Med. Chem., 14, 1940-1944.
31. Mukhopadhyay, A., Shishodia, S., Fu X.Y. and Aggarwal, B.B. (2002): Lack of reqirementt of STAT1 for activation of nuclear factor kappaB, c-Jun NH2-terminal protein Kinase, and apoptosis by tumor necrosis factor-alpha. J. Cell Biochem., 84, 803-815.
32. Neeb, L. and Reuter, U. (2007): Nitric oxide in migraine. CNS Neurol. Disord. Drug Targets, 6, 258-264.
33. Nyska, A., Lomnitski, L., Maronpot, R., Moomaw, C., Brodsky, B., Sintov, A. and Wormser, U. (2001): Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin. Arch. Toxicol., 74, 768-74.
34. Papirmeister, B., Feister, A.J., Robinson, S.I. and Ford, R.D. (1991): Medical defense against mustard gas: Toxic mechanisms and pharmacological implications. CRC Press, Boca Raton, Fl.
35. Paul, A., Cuenda, A., Brynt, C.E., Murray, J., Chilvers, E.R., Cohen, P., Gould, G.W. and Plevin, R. (1999): Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclooxygenas-2 but not nitric oxide synthase in RAW 264.7 macrophages. Cell Signal, 11, 491-497.
36. Petrali, J., Oglesby, S. and Mills, K. (1990): Ultrastructural correlates of sulfur mustard toxicity. J. Toxicol. (Cutaneous and Ocular Toxicology), 9, 193-214.
37. Qui, M., Paromov, V.M., Yang, H., Smith, M. and Stone, W. L. (2006): Inhibition of inducible nitric oxide synthase by a mustard gas analog in murine macrophages. BMC Cell Biol., 7, 39. (Pubitemid 44929345)
38. Rappeneau, S., Baeza-Squiben, A., Marano, F. and Calvet, J. (2000): Efficient protection of human bronchial epithelial cells against sulfur and nitrogen mustard cytotoxicity using drug combinations. Toxicol. Sci., 58, 153-160.
39. Rikimaru, T., Nakamura, M., Yano, T. and Beck, G. (1991): Mediators, initiating the inflammmatory response, released in organ culture by full thickness human skin explants exposed to the irritant, sulfur mustard. J. Invest. Dermatol., 96, 888-897.
40. Sawyer, T.W., Lundy, P.M. and Weiss, M.T. (1996): Protective effect of an inhibitor of nitric oxide synthase on sulphur mustard toxicity in-vitro. Toxicol. Appl. Pharmacol., 141, 138-144.
41. Sawyer, T.W., Hancock, J.R. and D'Agostino, P.A. (1998): I-thiocitrulline: A potent protective agent against the toxicity of sulphur mustard in vitro. Toxicol. Appl. Pharmacol., 151, 340-346.
42. Sawyer, T.W. and Risk, D. (2000): Effects of selected arginine analogues on sulfur mustard toxicity in human and hairless guinea pigs skin keratinodytes. Toxicol. Appl. Pharmacol., 163, 75-85.
43. Sawyer, T.W., Vair, C., Nelson, P., Shei, Y., Bjarnason, S., Tenn, C., McWilliams, M., Villanueva, M. and Burczyk, A. (2007): pH-dependent toxicity of sulphur mustard in vitro. Toxicol. Appl. Pharmacol., 221, 363-371.
44. Schafroth, T.S., Leuppi, J.D. (2007): Bronchial hyper-responsiveness and exhaled nitric oxide in chronic obstructive pulmonary disease. Swiss Med. Wkly., 137, 385-391.
45. Schmidt, H.H., Warner, T.D., Nakane, M., Förstermann, U. and Murad, F. (1992): Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol. Pharmacol., 41, 615-624.
46. Shapira, L., Sosklone, W.A., Houri, Y., Halabi, A. and Stabholz, A. (1996): Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect. Immun., 64, 825-828.
47. Stone, W.L., Qui, M. and Smith, M. (2003): Lipopolysaccharide enhances the cytotoxicity of 2-chloroethyl ethyl sulfide. BMC Cell Biol., 4, 1. (Pubitemid 38610621)
48. Tartagilia, L.A. and Goeddel, D.V. (1992): Two TNF receptors. Immunol. Today., 13, 151-153.
49. van Horssen, R., Ten Hagen, T.L.M. and Eggermont, A.M.M. (2006): TNF-α in cancer treatment: Molecular insights, antitumor effects and clinical utility. The Oncologist., 11, 397-408.
50. Watson, A.P. and Griffin, G.D. (1992): Toxicity of vesicant agents scheduled for destruction by the chemical stockpile disposal program. Environ. Health perspect., 98, 259-280.